ROLE OF URINARY CATIONS IN THE ETIOLOGY OF BLADDER SYMPTOMS AND INTERSTITIAL CYSTITIS.
Parsons CL, Shaw T, Berecz Z, Su Y, Zupkas P, Argade S. BJU Int. 2013 Dec 10. doi: 10.1111 
. [Epub ahead of print] PMID: 24325253
The aim of this study was to identify and characterize urinary cationic metabolites, defined as toxic factors, in patients with interstitial cystitis (IC) and control subjects and to evaluate the cytotoxicity of the urinary cationic metabolite fraction of patients with IC vs control subjects and of individual metabolites in cultured urothelial cells. Castro-Diaz D, Cardozo L, Chapple CR, Espuña M, Kelleher C, Kirby M, Milsom I, Sievert KD, Tubaro A. Int J Clin Pract. 2013 Dec 22. doi: 10.1111 . PMID: 24373133 The Overactive Bladder Syndrome (OAB) and the Bladder Pain Syndrome/Interstitial Cystitis (BPS/IC) are different urological conditions sharing 'urgency' as a common symptom. The aim of this review on urgency was to address existing knowledge and establish how these symptoms are interrelated and to determine whether or not there is a common link between both symptoms complexes that help to distinguish one from the other. Bladder pain with urgency should be a trigger for referral to the provider with appropriate knowledge and expertise in this disease state, whereas the management of OAB should be part of normal routine care in the community. Kartha GK, Kerr H, Shoskes DA. Curr Opin Urol. 2013 Nov; 23(6):560-4. doi: 10.1097 
URGENCY AND PAIN IN PATIENTS WITH OVERACTIVE BLADDER AND BLADDER PAIN SYNDROME. WHAT ARE THE DIFFERENCES?

CLINICAL PHENOTYPING OF UROLOGIC PAIN PATIENTS.
URINE ALKALIZATION IMPROVES THE PROBLEMS OF PAIN AND SLEEP IN HYPERSENSITIVE BLADDER SYNDROME.
Ueda T, Yoshida T, Tanoue H, Ito M, Tamaki M, Ito Y, Yoshimura N. Int J Urol. 2013 Nov 13. doi: 10.1111 
. [Epub ahead of print]. PMID: 24224617
This study investigated the efficacy of urine alkalization therapy using citrates in patients with hypersensitive bladder syndrome, concluding that urine alkalization therapy is likely to be effective in the treatment for hypersensitive bladder syndrome.
WHAT IS THE ROLE FOR BIOMARKERS FOR LOWER URINARY TRACT DISORDERS? ICI-RS 2013.
Fry CH, Sahai A, Vahabi B, Kanai AJ, Birder LA. Neurourol Urodyn. 2014 Jan 16. doi: 10.1002 
. [Epub ahead of print] PMID: 24436105
Fry et al look at biomarkers, noting that if a biomarker is to be of practical benefit then it must also be economical and practical to use. This article considers chemical moieties as biomarkers, although in principle physical markers (e.g., bladder wall thickness) could also be defined as such.
OPTIMIZATION OF A PAIN MODEL: EFFECTS OF BODY TEMPERATURE AND ANESTHESIA ON BLADDER NOCICEPTION IN MICE.
Sadler KE, Stratton JM, Deberry JJ, Kolber BJ. PLoS One. 2013 Nov 5; 8(11):e79617. doi: 10.1371/journal.pone.0079617. PMID: 24223980 Free full article, click on title Sadler and colleagues evaluated the effects of anesthesia induction and temperature variation in a mouse model of bladder pain known as urinary bladder distension (UBD).
GRADING OF EVIDENCE FOR BLADDER PAIN SYNDROME: A COMPARATIVE REVIEW OF STUDY QUALITY ASSESSMENT METHODS. Tirlapur SA, Khan KS. Int Urogynecol J. 2013 Nov 23. [Epub ahead of print] PMID: 24271457
Tirlapur and Khan compared the quality of evidence described in current BPS literature, concluding that GRADE, a refined method of assigning quality to evidence, provided a more conservative gauge, giving a realistic assessment of the value of recommendations for consideration in practice. Free full text, click on title Tirlapur et al report that they will conduct a prospective test validation study amongst women with unexplained CPP presenting to gynaecology outpatient clinics. The results of this test validation study will be used to identify whether a certain combination of signs and symptoms can accurately diagnose BPS. Free full article, click on title Lee et al found that LL-37 quickly induces release of ATP and apoptosis in the urothelium. These changes can be inhibited by a chemically-modified GAG, GM-0111. They also found that GAG analogs provide varying degrees of protection against LL-37 challenge in mice. They suggest that GM-0111 and possibly GAG molecules prevent the development of cystitis by blocking the apoptosis and the concurrent release of ATP from the urothelium.
BLADDER PAIN SYNDROME: VALIDATION OF SIMPLE TESTS FOR DIAGNOSIS IN WOMEN WITH CHRONIC
PREVENTION OF ANTI-MICROBIAL PEPTIDE LL-37-INDUCED APOPTOSIS AND ATP RELEASE IN THE URINARY
SEGMENTAL HYPERALGESIA TO MECHANICAL STIMULUS IN INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME -EVIDENCE OF CENTRAL SENSITIZATION.
Lai HH, Gardner V, Ness TJ, Gereau RW 4th. J Urol. 2013 Dec 5. pii: S0022-5347(13) 06071-0. doi: 10.1016/j.juro.2013.11.099 
. [Epub ahead of print] PMID: 24316091
Lai et found that female subjects with IC/BPS showed segmental hyperalgesia to mechanical pressure stimulation in the suprapubic area (T10-T12). This segmental hyperalgesia may be explained in part by spinal central sensitization.
CHARACTERIZATION OF BLADDER SENSORY NEURONS IN THE CONTEXT OF MYELINATION, RECEPTORS FOR PAIN MODULATORS, AND ACUTE RESPONSES TO BLADDER INFLAMMATION.
Forrest SL, Osborne PB, Keast JR. Front Neurosci. 2013 Nov 7; 7:206. doi: 10.3389/fnins.2013.00206. PMID: 24223534 Free full article, click on title Forrest et al note that bladder sensation is mediated by lumbosacral dorsal root ganglion neurons and is essential for normal voiding and nociception. Their study identified a sub-population of sacral sensory neurons that are likely to be undergoing structural remodelling during acute inflammation of the bladder. Lee JD, Lee MH. Urology. 2013 Dec; 82(6):1451 82(6): .e7-1451 82(6): .e11. doi: 10.1016 82(6): /j.urology.2013 Lee & Lee investigated the intrinsic or extrinsic pathway of apoptosis from bladder biopsy that was performed in interstitial cystitis/painful bladder syndrome (IC/PBS). They suggest that this study might help to clarify the molecular changes and lead to a better understanding of this bladder disease. Kitta T, Chancellor MB, de Groat WC, Kuno S, Nonomura K, Yoshimura N. Neurourol Urodyn. 2013 Sep 9. doi: 10.1002 . PMID: 24014261 Kitta et al examined the role of adenosine A1 and A2A receptors in the control of bladder activity in rats with normal or acetic acid (AA) irritated bladders, suggesting that adenosine A1 receptor agonists and A2A receptor antagonists might be effective for the treatment of overactive bladder and/or bladder hypersensitive disorders, in which C-fiber afferent function is enhanced. Guo C, Yang B, Gu W, Peng B, Xia S, Yang F, Wen D, Geng J, Zhang Y, Zheng J. PLoS One. 2013 Dec 20; 8(12):e82591. doi: 10.1371/journal.pone.0082591. PMID: 24376550 Free full text, click on title While Resiniferatoxin (RTX) has been widely used for patients with storage lower urinary tract symptoms (LUTS), its clinical efficiency has not yet been well evaluated. Guo et al report that great caution should be taken when intravesical RTX is used before a large, multicentre, well-designed random control trial with a longterm follow-up is carried out to further assess the clinical efficacy of RTX in patients with storage LUTS. 
ACTIVATION OF EXTRINSIC APOPTOTIC PATHWAY FROM BLADDER BIOPSY IN PATIENTS WITH INTERSTITIAL CYSTITIS/PAINFUL BLADDER SYNDROME
ROLES OF ADENOSINE A1 AND A2A RECEPTORS IN THE CONTROL OF MICTURITION IN RATS.
INTRAVESICAL RESINIFERATOXIN FOR THE TREATMENT OF STORAGE LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH EITHER INTERSTITIAL CYSTITIS OR DETRUSOR OVERACTIVITY: A META-ANALYSIS.
A MULTICENTRE, PROSPECTIVE, RANDOMISED, DOUBLE-BLIND STUDY TO MEASURE THE TREATMENT EFFECTIVENESS OF ABOBOTULINUM
